Medusa is a modern hybrid strain with an undocumented lineage, as its precise parentage remains unknown. Designed for versatility, the cultivar performs well in both indoor and outdoor environments, requiring moderate cultivation experience to manage properly. Under optimal conditions, growers can expect a high yield from this plant, which reaches maturity after a flowering period of 63 days. Its genetic impact on the contemporary landscape is established through its role as a parent to the Cross of The Titans.

The complex organoleptic profile of Medusa is defined by a deep hierarchical dominance of caryophyllene, myrcene, and limonene, followed by pinene, humulene, and ocimene. The chemical spectrum continues with smaller concentrations of nerolidol, linalool, beta-pinene, guaiol, and p-cymene, rounded out by traces of bisabolol, eucalyptol, camphene, and caryophyllene-oxide. This broad range of terpenes provides a nuanced aromatic experience that reflects the strain's intricate chemical composition.

As a THC-dominant variety, Medusa is recognized for its ability to produce relaxed, happy, and uplifted states. These psychoactive effects make it a functional choice for individuals addressing symptoms of stress, physical pain, or difficulty with sleep. By serving as the foundation for the Cross of The Titans, Medusa continues to influence current breeding efforts, cementing its utility as both a therapeutic option and a genetic building block.